Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0634 CHF | +0.63% | +16.97% | +54.63% |
05-01 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
04-17 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+54.63% | 4.7M | |
-2.61% | 88.47B | |
+3.55% | 40.71B | |
-14.09% | 32.43B | |
+55.89% | 24.28B | |
-16.05% | 15.52B | |
-41.29% | 12.17B | |
-15.54% | 12.01B | |
-11.75% | 12B | |
+7.87% | 8.87B |
- Stock Market
- Equities
- POLN Stock
- News Spexis AG
- Spexis Enlists Financial Adviser to Evaluate Strategic Alternatives, Fundraising Opportunities